Parkinson's disease Improved function with GMl ganglioside treatment in a randomized placebo‐controlled study

Abstract

This study demonstrates that GM1 ganglioside treatment enhances neurologic function significantly in PD patients. Further study is warranted to evaluate long-term effects of GM1 in PD patients and to elucidate further the mechanisms underlying patient improvements.